DUNK yields 9.88% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, DUNK + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DUNK + PFE for your $10,000?
DUNK invests in companies driving or adapting to disruptive trends such as e-commerce, cloud computing, digital advertising, electric vehicles, biotechnology, and artificial intelligence. The fund typically holds 1530 stocks selected for solid fundamentals, disciplined valuations, and participation in long-term profit trends tied to these themes. While it emphasizes large-cap names, it can also invest in smaller companies and add foreign exposure through depositary receipts or emerging-market holdings when appropriate. Individual positions are limited to 15% of assets, and up to 20% may be held in cash to maintain flexibility. This high-conviction approach allows the portfolio to adjust quickly as new opportunities emerge across sectors. By combining valuation discipline with a focus on disruptive growth, the strategy seeks to capture innovation-driven gains while reducing the risk of overpaying for popular themes.
Full DUNK Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.